Cutaneous bruising - Causes, Treatment & When to See a Doctor

```html

What is Cutaneous Bruising?

Cutaneous bruising, commonly called a bruise or contusion, is a discoloration of the skin that occurs when small blood vessels (capillaries) under the surface are ruptured. Blood leaks into the surrounding tissue, producing a blue‑purple patch that changes colour over days as the body reabsorbs the blood. While bruises are usually harmless and resolve on their own, they can sometimes signal an underlying medical problem, especially when they appear spontaneously, are extensive, or are accompanied by other concerning signs.

Typical bruise progression:

• Day 0‑2: Red or dark purple.
• Day 3‑5: Blue‑black.
• Day 5‑7: Greenish.
• Day 7‑10: Yellowish‑brown.

Understanding why a bruise forms and when it might be a warning sign helps patients seek timely care and avoid unnecessary complications.

Common Causes

Bruising can result from a wide variety of sources. Below are the most frequently encountered causes, grouped by mechanism.

• Mechanical Trauma – bump, fall, sports injury, or blunt force.
• Medications & Supplements – aspirin, ibuprofen, clopidogrel, warfarin, heparin, fish‑oil, ginkgo, or high‑dose vitamin E.
• Bleeding Disorders – hemophilia A or B, von Willebrand disease, platelet function defects.
• Vitamin Deficiencies – especially vitamin C (scurvy) and vitamin K.
• Age‑Related Skin Changes – thinning dermis and reduced collagen in older adults.
• Systemic Diseases – liver cirrhosis, chronic kidney disease, leukemia, myeloma, and other hematologic malignancies.
• Connective‑Tissue Disorders – Ehlers‑Danlos syndrome, Marfan syndrome, or other collagen‑vascular diseases.
• Infections – sepsis, meningococcemia, or viral infections that cause thrombocytopenia (e.g., dengue, HIV).
• Autoimmune Conditions – immune thrombocytopenic purpura (ITP), systemic lupus erythematosus (SLE).
• Hormonal/Metabolic Factors – pregnancy‑related vascular changes or uncontrolled diabetes leading to fragile vessels.

Associated Symptoms

Bruising rarely occurs in isolation. The presence of additional signs can help pinpoint the underlying cause.

• Pain or tenderness at the bruised site (common with trauma).
• Swelling or warmth – may suggest an underlying hematoma or infection.
• Easy bleeding from gums, nose, or minor cuts.
• Petechiae or purpura – tiny red spots that don’t blanch, indicating platelet or clotting problems.
• Fatigue, fever, or weight loss – red flags for malignancy or systemic infection.
• Jaundice, abdominal swelling, or ascites – point toward liver disease.
• Joint pain or swelling – may accompany connective‑tissue disorders.

When to See a Doctor

Most bruises heal without medical attention, but you should schedule an appointment if any of the following apply:

• Bruises appear without any clear injury or after minimal trauma.
• You develop multiple new bruises over a short period (e.g., several per week).
• Bruising is accompanied by excessive bleeding from cuts, gums, or the nose.
• You notice large or painful hematomas that do not improve within 2 weeks.
• Bruising is associated with unexplained fatigue, fever, night sweats, or weight loss.
• You are taking blood‑thinning medication and the bruise is rapidly expanding or extremely tender.
• You have a known bleeding disorder and notice a sudden change in bruising pattern.

Diagnosis

Evaluating cutaneous bruising involves a combination of history‑taking, physical examination, and targeted investigations.

1. Medical History

• Onset, location, size, and progression of the bruise.
• Recent trauma or falls.
• Medication and supplement use (including over‑the‑counter NSAIDs).
• Family history of bleeding disorders.
• Associated systemic symptoms (fever, weight loss, easy bruising elsewhere).

2. Physical Examination

• Inspection of the bruise: color, size, borders, and any surrounding swelling.
• Palpation for tenderness, fluctuance (suggesting a hematoma), or signs of infection.
• Survey of other skin areas for petechiae, purpura, or ecchymoses.
• Evaluation of liver size, spleen enlargement, and lymph nodes.

3. Laboratory Tests (ordered based on suspicion)

• Complete blood count (CBC) – looks for anemia, thrombocytopenia, or leukocytosis.
• Prothrombin time (PT) / INR and activated partial thromboplastin time (aPTT) – assess clotting cascade.
• Serum vitamin C and K levels if deficiency is suspected.
• Liver function tests (AST, ALT, bilirubin, albumin) – evaluate hepatic contribution.
• Kidney function panel – especially in patients with CKD.
• Coagulation factor assays (VIII, IX) if hemophilia is a concern.
• Autoimmune work‑up – ANA, anti‑platelet antibodies for ITP or SLE.

4. Imaging (when indicated)

• Ultrasound – differentiates simple bruises from deeper hematomas or vascular lesions.
• CT or MRI – used when trauma may involve underlying bone, organ injury, or when suspecting a malignancy.

Treatment Options

Treatment is tailored to the underlying cause and the severity of the bruise.

1. General Self‑Care (for simple traumatic bruises)

• Cold compress – apply a clean ice pack (wrapped in a cloth) for 10‑15 minutes, every 2‑3 hours during the first 24‑48 hours to reduce bleeding.
• Elevation of the affected limb to decrease hydrostatic pressure.
• Compression with a soft bandage (if no arterial injury is suspected).
• Gentle analgesics such as acetaminophen (avoid NSAIDs if bleeding risk is high).
• Allow the bruise to “breathe”; do not apply heat in the first 48 hours.

2. Medication‑Related Adjustments

• Discuss with your prescribing physician whether blood‑thinners can be dose‑adjusted or temporarily held.
• Consider switching to a medication with a shorter half‑life if frequent bruising is problematic.

3. Targeted Medical Therapies

• Vitamin supplementation – oral vitamin C (500‑1000 mg daily) or vitamin K (2–5 mg daily) when deficiencies are documented.
• Desmopressin (DDAVP) – used in mild hemophilia A or vWD to boost factor VIII and von Willebrand factor.
• Tranexamic acid – antifibrinolytic agent for patients with excessive bleeding (prescribed under supervision).
• Immunosuppressive therapy – corticosteroids, IVIG, or rituximab for immune thrombocytopenic purpura.
• Antifibrotic or disease‑modifying agents – for underlying connective‑tissue disorders (e.g., beta‑blockers for Marfan‑related vascular fragility).
• Management of liver disease (e.g., vitamin K, plasma transfusion) or hematologic malignancies (chemotherapy/targeted therapy) as per specialist recommendations.

4. Procedural Interventions

• Drainage of large hematomas – performed by a surgeon or interventional radiologist if the collection is painful, threatens skin integrity, or impairs function.
• Platelet or plasma transfusion – in acute bleeding episodes for patients with severe thrombocytopenia or coagulation factor deficiency.

Prevention Tips

While some bruising is inevitable, especially as we age, many steps can reduce frequency and severity.

• Protect vulnerable areas – wear padded gloves, knee pads, or elbow guards during sports or manual labor.
• Maintain a balanced diet rich in leafy greens (vitamin K), citrus fruits (vitamin C), and protein for tissue repair.
• Stay hydrated – adequate fluid intake keeps blood volume optimal.
• Limit or review use of blood‑thinners with your clinician, especially if you notice new bruises.
• Control chronic conditions such as hypertension, diabetes, and liver disease, which can weaken vessel walls.
• Exercise safely – incorporate strength training to improve muscle support around joints, reducing impact on vessels.
• Avoid smoking – tobacco damages capillaries and impairs healing.
• Regular check‑ups if you have a known bleeding disorder or take anticoagulant therapy.

Emergency Warning Signs

---

Understanding cutaneous bruising helps differentiate a harmless cosmetic concern from a sign of a more serious medical condition. By recognizing common causes, associated symptoms, and red‑flag warnings, patients can act promptly and collaborate effectively with their healthcare providers.

Sources: Mayo Clinic, CDC, National Institutes of Health (NIH), World Health Organization (WHO), Cleveland Clinic, UpToDate, Journal of Hematology & Oncology.

```